Sign in

CIK 0001739410 · <br>Emerging growth company

Rallybio Corp

Sign in to watch
Ticker
RLYB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851083789
Phone
203- 859-3820
Business address
234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
Former names
Rallybio Holdings, LLC
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G Stake Amended Statement of Ownership
  3. 4 Open-market sale 10% owner sold 210,000 shares at $13.05 ($2,740,500)
  4. 4 Open-market sale Director sold 210,000 shares at $13.05 ($2,740,500)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. SC 13G Stake Amended Statement of Ownership
  10. 4 Open-market buy See Remarks bought 1,400 shares at $8.70 ($12,180)
  11. SC 13G Stake Amended Statement of Ownership
  12. SC 13D/A Stake Beneficial Ownership Report
  13. 4 Open-market buy See Remarks bought 10,000 shares at an average $9.85 ($98,502)
  14. 4 Open-market buy Chief Executive Officer bought 10,000 shares at an average $10.35 ($103,473)
  15. 4 Open-market buy See Remarks bought 10,000 shares at an average $9.41 ($94,069)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 13 of 16 · 312 filings